ATE314390T1 - Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren - Google Patents

Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren

Info

Publication number
ATE314390T1
ATE314390T1 AT98945924T AT98945924T ATE314390T1 AT E314390 T1 ATE314390 T1 AT E314390T1 AT 98945924 T AT98945924 T AT 98945924T AT 98945924 T AT98945924 T AT 98945924T AT E314390 T1 ATE314390 T1 AT E314390T1
Authority
AT
Austria
Prior art keywords
genetically manipulated
manipulated cells
bone morphogenesis
proteins
express bone
Prior art date
Application number
AT98945924T
Other languages
English (en)
Inventor
Ioannis Moutsatsos
Dan Gazit
Yoram Zilberman
Gadi Turgeman
Original Assignee
Inst Genetics Llc
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc, Yissum Res Dev Co filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of ATE314390T1 publication Critical patent/ATE314390T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT98945924T 1997-09-05 1998-09-04 Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren ATE314390T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5798997P 1997-09-05 1997-09-05
US09/148,234 US20020102728A1 (en) 1997-09-05 1998-09-04 Genetically engineered cells which express bone morphogenetic proteins
PCT/US1998/018603 WO1999011664A1 (en) 1997-09-05 1998-09-04 Genetically engineered cells which express bone morphogenetic proteins

Publications (1)

Publication Number Publication Date
ATE314390T1 true ATE314390T1 (de) 2006-01-15

Family

ID=22013954

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945924T ATE314390T1 (de) 1997-09-05 1998-09-04 Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren

Country Status (12)

Country Link
US (2) US20020102728A1 (de)
EP (1) EP1007559B1 (de)
JP (1) JP2001514026A (de)
AT (1) ATE314390T1 (de)
AU (1) AU752556B2 (de)
CA (1) CA2301882A1 (de)
DE (1) DE69832989T2 (de)
DK (1) DK1007559T3 (de)
ES (1) ES2255180T3 (de)
MX (1) MXPA00002318A (de)
PT (1) PT1007559E (de)
WO (1) WO1999011664A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186283A1 (en) 1997-10-10 2005-08-25 Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie Collagen carrier of therapeutic genetic material, and method
US8858981B2 (en) 1997-10-10 2014-10-14 Ed. Geistlich Soehne Fuer Chemistrie Industrie Bone healing material comprising matrix carrying bone-forming cells
US9034315B2 (en) 1997-10-10 2015-05-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Cell-charged multi-layer collagen membrane
MXPA02000877A (es) * 1999-07-28 2002-08-06 Regeneration Tech Inc Matriz de hueso o cartilago como un vehiculo para suministro de acido nucleico.
US6939540B1 (en) * 2000-07-31 2005-09-06 Cornell Research Foundation, Inc. Method of enhancing bone density
WO2003013588A1 (fr) * 2001-08-08 2003-02-20 Kaken Pharmaceutical Co., Ltd. Materiau de regeneration de rein comprenant des cellules et un facteur de croissance cellulaire
AU2002300450B2 (en) * 2001-08-10 2007-04-05 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Collagen Carrier of Therapeutic Genetic Material, and Method
JP4097544B2 (ja) * 2003-02-27 2008-06-11 独立行政法人理化学研究所 人工リンパ節
AU2004255245B2 (en) * 2003-07-09 2009-10-22 Warsaw Orthopedic, Inc. Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation
US20050272678A1 (en) * 2004-02-11 2005-12-08 Bodine Peter Van N BMP-6 estrogen responsive element and methods of use thereof
US7531355B2 (en) * 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
US20120263692A1 (en) * 2009-11-16 2012-10-18 Bertone Alicia L Engineered Xenogeneic Cells for Repair of Biological Tissue
EP3359175B1 (de) 2015-10-05 2020-09-16 Salk Institute for Biological Studies Synthetische adenoviren mit tropismus gegen geschädigtes gewebe zur förderung der wundheilung und geweberegeneration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
WO1996039431A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Bone morphogenic protein-10

Also Published As

Publication number Publication date
AU9306298A (en) 1999-03-22
JP2001514026A (ja) 2001-09-11
PT1007559E (pt) 2006-05-31
US20020102728A1 (en) 2002-08-01
AU752556B2 (en) 2002-09-19
EP1007559A1 (de) 2000-06-14
MXPA00002318A (es) 2006-02-22
CA2301882A1 (en) 1999-03-11
US20110111505A1 (en) 2011-05-12
EP1007559B1 (de) 2005-12-28
DK1007559T3 (da) 2006-05-08
WO1999011664A1 (en) 1999-03-11
ES2255180T3 (es) 2006-06-16
DE69832989D1 (de) 2006-02-02
DE69832989T2 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
ATE314390T1 (de) Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren
ATE540973T1 (de) Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
IL150566A0 (en) Nucleic acids and polypeptides and nogo-receptor proteins
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
WO1999035262A3 (en) Apoptosis inducing molecule ii
WO1999040197A3 (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
WO2002014358A3 (en) Novel secreted proteins and their uses
ATE391778T1 (de) Mutanten des vaskulären, endothelzellen- spezifischen wachstumsfaktors c (vegf-c) und deren verwendungen
DE69819167D1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
NZ510367A (en) Interleukin 17-like receptor protein nucleic acid sequence encoding the interleukin receptor protein and method of expressing protein in recombinant vector
WO1998049300A3 (en) Truncated vegf-related proteins
DE60018920D1 (de) Rekombinante adenovirale vektoren, die chimäre fiberproteine exprimieren, für die zellspezifische infektion und genomische integration
WO2001098491A3 (en) Osteolevin gene polymorphisms
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
WO2002050111A3 (en) Isolated laminin 10
FI971896A (fi) BMP-tyyppi II-reseptoria koodaava cDNA
BR9812138A (pt) Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta
WO2000061774A3 (en) Bone morphogenic proteins
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
HK1002284A1 (en) Novel implant and novel vector for the treatment of acquired diseases
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
AR025482A1 (es) Secuencia de adn que codifica una proteina capaz de ligarse a traf; vector que comprende dicha secuencia; celulas huespedes transformadas con dicho vector;proteinas iren codificadas por dicha secuencia; metodo para producir dicha proteina; anticuerpos especificos para dichas proteinas; metodo para m
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
WO1998031805A3 (en) Human zinc binding proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007559

Country of ref document: EP